Spectrum Pharmaceuticals Inc financial data

Location
11500 S. Eastern Ave., Suite 240, Henderson, NV
State of incorporation
DE
Fiscal year end
December 31
Former names
NEOTHERAPEUTICS INC (to 12/11/2002)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 228 % -6.35%
Debt-to-equity 230 % +175%
Return On Equity -210 % -10.1%
Return On Assets -63.5 % +38.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 205M shares +15.9%
Common Stock, Shares, Outstanding 205M shares +14.8%
Entity Public Float 115M USD -67.4%
Common Stock, Value, Issued 205K USD +14.5%
Weighted Average Number of Shares Outstanding, Basic 202M shares +19%
Weighted Average Number of Shares Outstanding, Diluted 202M shares +19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.6M USD
Research and Development Expense 43.4M USD -39.8%
Costs and Expenses 89.2M USD -30.3%
Operating Income (Loss) -63.5M USD +50.4%
Nonoperating Income (Expense) -4.17M USD +58.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.7M USD +51%
Income Tax Expense (Benefit) 30K USD +11.1%
Net Income (Loss) Attributable to Parent -65M USD +53.1%
Earnings Per Share, Basic -0.34 USD/shares +60.5%
Earnings Per Share, Diluted -0.34 USD/shares +60.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.4M USD -33.4%
Cash, Cash Equivalents, and Short-term Investments 56.1M USD -37.1%
Accounts Receivable, after Allowance for Credit Loss, Current 32.8M USD
Inventory, Net 12.9M USD
Assets, Current 105M USD +13.1%
Property, Plant and Equipment, Net 534K USD +27.8%
Operating Lease, Right-of-Use Asset 1.52M USD -28%
Other Assets, Noncurrent 245K USD -94.4%
Assets 108M USD +7.62%
Contract with Customer, Liability, Current 8.11M USD
Liabilities, Current 38.9M USD -0.83%
Operating Lease, Liability, Noncurrent 858K USD -33.8%
Other Liabilities, Noncurrent 13.1M USD +135%
Liabilities 80.9M USD +80.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.89M USD +0.72%
Retained Earnings (Accumulated Deficit) -1.12B USD -6.13%
Stockholders' Equity Attributable to Parent 26.8M USD -51.5%
Liabilities and Equity 108M USD +7.62%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.4M USD +29.2%
Net Cash Provided by (Used in) Financing Activities 2.11M USD -89.4%
Net Cash Provided by (Used in) Investing Activities 31.3M USD +7220%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 205M shares +14.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.4M USD -33.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 767K USD
Deferred Tax Assets, Valuation Allowance 256M USD +5.55%
Deferred Tax Assets, Gross 257M USD +5.04%
Operating Lease, Liability 1.63M USD -29.1%
Payments to Acquire Property, Plant, and Equipment 108K USD +177%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.9M USD +52.9%
Lessee, Operating Lease, Liability, to be Paid 1.69M USD -29.2%
Operating Lease, Liability, Current 771K USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD -71.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 820K USD +24.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -32.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 73K USD -25.5%
Deferred Tax Assets, Operating Loss Carryforwards 198M USD +5.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.63M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year Four 73K USD -25.5%
Operating Lease, Payments 208K USD -64.4%
Additional Paid in Capital 1.15B USD +3.26%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 45K USD -38.4%
Deferred Tax Assets, Net of Valuation Allowance 522K USD -69.1%
Share-based Payment Arrangement, Expense 7.26M USD -61.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%